Live from the NIH registry
Studies recruiting near Nashua right now
Top 25 of 262 recruiting studies, sorted by proximity — each links to its official registry page
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 495 participants sought
Lahey Hospital and Medical Center — Burlington, Massachusetts (22.6 mi)
· Sponsor: AB Science
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Dartmouth Cancer Center - Nashua — Nashua, New Hampshire (1.6 mi)
· Sponsor: SWOG Cancer Research Network
Direct to Patient Minimal Risk Biospecimen and Data Collection Research
Healthy, Lupus
N/A
Observational 100,000 participants sought
Joined Bio — Lexington, Massachusetts (24.9 mi)
· Sponsor: Joined Bio
Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease
Dry Eye Disease (DED)
Phase 4
Interventional 60 participants sought
Andover Eye Associates — Andover, Massachusetts (19.0 mi)
· Sponsor: Andover Research Eye Institute
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Age-Related Macular Degeneration, Geographic Atrophy
N/A
Interventional 125 participants sought
Tallman Eye Associates — Lawrence, Massachusetts (16.9 mi)
· Sponsor: VisionCare, Inc.
Cerebellar TMS and Satiety in Prader-Willi Syndrome
Prader-Willi Syndrome
N/A
Interventional 20 participants sought
McLean Hospital — Belmont, Massachusetts (29.1 mi)
· Sponsor: Brigham and Women's Hospital
Prediction Augmented Screening Initiative
Lung Cancer, Lung Cancer Screening
N/A
Interventional 23,520 participants sought
VA Bedford HealthCare System, Bedford, MA — Bedford, Massachusetts (20.9 mi)
· Sponsor: VA Office of Research and Development
ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Inflammatory Bowel Syndrome
N/A
Observational 220 participants sought
ALPCO — Salem, New Hampshire (15.0 mi)
· Sponsor: American Laboratory Products Company
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (17.1 mi)
· Sponsor: American Society of Clinical Oncology
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
Gastrointestinal Cancer, Hematologic Cancer
N/A
Interventional 210 participants sought
Dana-Farber Cancer Instiute - Merrimack Valley — Methuen, Massachusetts (15.3 mi)
· Sponsor: Nadine McCleary, MD, MPH
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
Major Depressive Disorder
N/A
Observational 228 participants sought
McLean Hospital — Belmont, Massachusetts (29.1 mi)
· Sponsor: Mclean Hospital
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
Alzheimer Disease, Dementia Alzheimers
N/A
Observational 40 participants sought
McLean Hospital — Belmont, Massachusetts (29.1 mi)
· Sponsor: Mclean Hospital
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
Diabetes Mellitus, Hypertension
N/A
Interventional 1,022 participants sought
Dartmouth Hitchcock Clinics Manchester — Manchester, New Hampshire (17.1 mi)
· Sponsor: Dartmouth-Hitchcock Medical Center
Preliminary Trial of an Avatar Guided Digital Intervention for Emerging Adults
Binge Alcohol Consumption, Suicidal Ideation
N/A
Interventional 60 participants sought
UMass Memorial Health - Marlborough Hospital — Marlborough, Massachusetts (28.0 mi)
· Sponsor: University of Massachusetts, Worcester
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Alzheimer Disease, Dementia
Phase 3
Interventional 550 participants sought
MedVadis Research Corporation — Waltham, Massachusetts (28.8 mi)
· Sponsor: Eli Lilly and Company
BostonGene-Integrated Genomic Registry (BIGR)
Malignancy
N/A
Observational 100,000 participants sought
BostonGene — Waltham, Massachusetts (28.8 mi)
· Sponsor: BostonGene
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Southern New Hampshire Diabetes and Endocrinology /ID# 257841 — Nashua, New Hampshire (1.6 mi)
· Sponsor: AbbVie
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
Bipolar Disorder, Bipolar Disorder Type 1
N/A
Interventional 100 participants sought
McLean Hospital — Belmont, Massachusetts (29.1 mi)
· Sponsor: Stony Brook University
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
Acute Respiratory Distress Syndrome (ARDS), ARDS
Phase 2
Interventional 200 participants sought
Lahey Hospital and Medical Center — Burlington, Massachusetts (22.6 mi)
· Sponsor: PPD Development, LP
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Obesity, Overweight
Phase 3
Interventional 1,100 participants sought
ACCOMPLISH-2 Research Site — Methuen, Massachusetts (15.3 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Tufts Medical Center Cancer Center Stoneham — Stoneham, Massachusetts (27.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Utilizing Battlefield Acupuncture to Treat Chronic Pain
Chronic Pain, Substance Use Disorders
N/A
Interventional 125 participants sought
Bedford VA Healthcare System — Bedford, Massachusetts (20.9 mi)
· Sponsor: Edith Nourse Rogers Memorial Veterans Hospital
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 700 participants sought
Lahey Hospital & Medical Center — Burlington, Massachusetts (22.6 mi)
· Sponsor: Eli Lilly and Company
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
MedVadis Research — Waltham, Massachusetts (28.8 mi)
· Sponsor: Crystalys Therapeutics
A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
Phelan-McDermid Syndrome
Phase 3
Interventional 160 participants sought
Neuren PMS-301 Site#104 — Lexington, Massachusetts (24.9 mi)
· Sponsor: Neuren Pharmaceuticals Limited